E-LIB Suche - Ergebnisse für: Traugott, Kristi

1

2819. Clinical Outcomes of Fosfomycin Treatment in E. coli ..:

Traugott, Kristi ; Lee, Grace ; Groff, Lindsey.
Open Forum Infectious Diseases. 10 (2023) Supplement_2 - p. , 2023

2

204. Clinical Outcomes with Ceftaroline Monotherapy versus ..:

Andonie, Gabriela ; Hand, Elizabeth O ; Reveles, Kelly R.
Open Forum Infectious Diseases. 8 (2021) Supplement_1 - p. S209-S210 , 2021

Link: https://doi.org/10.1093/..

3

608. Impact of Implementing Pharmacist Review and Monitorin..:

Kirkpatrick, Emily R ; Hand, Elizabeth O ; Hughes, Darrel W..
Open Forum Infectious Diseases. 7 (2020) Supplement_1 - p. S365-S365 , 2020

Link: https://doi.org/10.1093/..

4

150. Urinary Tract-Associated Gram-Negative Bacteremia: Imp..:

Badwal, Jasmin K ; Hand, Elizabeth O ; Lyons, John M.
Open Forum Infectious Diseases. 6 (2019) Supplement_2 - p. S102-S102 , 2019

Link: https://doi.org/10.1093/..

5

2419. Standard vs. Alternative Therapy for Stenotrophomonas..:

Badwal, Jasmin ; Traugott, Kristi ; Hand, Elizabeth
Open Forum Infectious Diseases. 5 (2018) suppl_1 - p. S723-S723 , 2018

Link: https://doi.org/10.1093/..

6

β‐Lactam Therapy for Methicillin‐Susceptible Staphylococcus..:

Li, Julius ; Echevarria, Kelly L. ; Traugott, Kristi A.
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 37 (2017) 3 - p. 346-360 , 2017

Link: https://doi.org/10.1002/..

7

Molecular and Microbiological Evaluation of Carbapenem-Resi..:

Serrano, Ruth ; Matheu, Michelle ; Perez, Federico...
Open Forum Infectious Diseases. 4 (2017) suppl_1 - p. S139-S140 , 2017

Link: https://doi.org/10.1093/..

8

Ceftaroline as Salvage Monotherapy for Persistent MRSA Bact..:

Burnett, Yvonne J. ; Echevarria, Kelly ; Traugott, Kristi A.
Annals of Pharmacotherapy. 50 (2016) 12 - p. 1051-1059 , 2016

Link: https://doi.org/10.1177/..

9

In Vitro Susceptibility Testing of Essential Oils Against C..:

Patterson, Jan E. ; Cadena, Jose ; Traugott, Kristi..
Open Forum Infectious Diseases. 3 (2016) suppl_1 - p. , 2016

Link: https://doi.org/10.1093/..

10

A clinical pathway for community-acquired pneumonia: an obs..:

Frei, Christopher R ; Bell, Allison M ; Traugott, Kristi A...
BMC Infectious Diseases. 11 (2011) 1 - p. , 2011

Link: https://doi.org/10.1186/..

11

Effects of therapeutic drug monitoring criteria in a comput..:

Traugott, Kristi A. ; Maxwell, Pamela R. ; Green, Kay..
American Journal of Health-System Pharmacy. 68 (2011) 4 - p. 347-352 , 2011

Link: https://doi.org/10.2146/..

12

Monotherapy or Combination Therapy? The Pseudomonas aerugin..:

Traugott, Kristi A. ; Echevarria, Kelly ; Maxwell, Pamela..
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 31 (2011) 6 - p. 598-608 , 2011

Link: https://doi.org/10.1592/..

13

608. Impact of Implementing Pharmacist Review and Monitorin..:

Kirkpatrick, Emily R ; Hand, Elizabeth O ; Hughes, Darrel W..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776687/. , 2020

Link: http://www.ncbi.nlm.nih...

14

150. Urinary Tract-Associated Gram-Negative Bacteremia: Imp..:

Badwal, Jasmin K ; Hand, Elizabeth O ; Lyons, John M.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810618/. , 2019

Link: http://www.ncbi.nlm.nih...

15

2419. Standard vs. Alternative Therapy for Stenotrophomonas..:

Badwal, Jasmin ; Traugott, Kristi ; Hand, Elizabeth
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253448/. , 2018

Link: http://www.ncbi.nlm.nih...